Marc J. Yoskowitz
CIK: 0001617306
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 15, 2026No ticker
Keenova Therapeutics plc
Award(A)DirectRestricted Stock Units
4.4K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Tax Payment(F)Direct825 shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Disposition(D)DirectRestricted Stock Units
2.9K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Exercise(M)Direct3.6K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
Award(A)DirectShare Options (Right to buy)
66K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
Award(A)DirectDeferred Restricted Stock Units
96.2K shares- - Feb 23, 2026No ticker
Keenova Therapeutics plc
Award(A)DirectRestricted Stock Units
5.3K shares- - Oct 20, 2025No ticker
Mallinckrodt plc
Award(A)DirectRestricted Stock Units
1.4K shares- - Aug 14, 2025No ticker
Mallinckrodt plc
Award(A)DirectRestricted Stock Units
4.1K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
Award(A)DirectDeferred Restricted Stock Units
13.7K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
Award(A)DirectShare Options (Right to buy)
55K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  No ticker Keenova Therapeutics plc | Award(A) Restricted Stock Units | 4,406 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Tax Payment(F) | 825 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Disposition(D) Restricted Stock Units | 2,930 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Exercise(M) | 3,579 | - | $0 | Direct |
| Feb 26, 2026 |  MREO Mereo BioPharma Group plc | Award(A) Share Options (Right to buy) | 66,000 | - | - | Direct |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award(A) Deferred Restricted Stock Units | 96,163 | - | - | Direct |
| Feb 23, 2026 | No ticker Keenova Therapeutics plc | Award(A) Restricted Stock Units | 5,312 | - | - | Direct |
| Oct 20, 2025 | No ticker Mallinckrodt plc | Award(A) Restricted Stock Units | 1,354 | - | - | Direct |
| Aug 14, 2025 | No ticker Mallinckrodt plc | Award(A) Restricted Stock Units | 4,062 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award(A) Deferred Restricted Stock Units | 13,719 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award(A) Share Options (Right to buy) | 55,000 | - | - | Direct |
1-11 of 11 transactions
About Yoskowitz Marc J
Yoskowitz Marc J (SEC CIK 0001617306) files insider reports with the SEC as Director of Keenova Therapeutics plc and Director of Mereo BioPharma Group plc (MREO).
Signal8 holds 8 ownership filings by Yoskowitz Marc J (1 Form 3, 7 Form 4), filed between Feb 6, 2025 and Jul 17, 2026. Those filings report 11 transactions, from Feb 5, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yoskowitz Marc J's filings is in BRIDGEWATER, NJ.
Recent filings by Yoskowitz Marc J
- Jul 15, 2026: Grant or award of Keenova Therapeutics plc derivative securities (Form 4, code A).
- Jun 2, 2026: Tax withholding of Keenova Therapeutics plc shares (Form 4, code F).
- Jun 2, 2026: Disposition to issuer transaction of Keenova Therapeutics plc derivative securities (Form 4, code D).
- Jun 2, 2026: Option exercise of Keenova Therapeutics plc shares (Form 4, code M).
- Feb 26, 2026: Grants or awards of MREO derivative securities (2 lines, Form 4, code A).